Genetics & Population Health Division, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
J Invest Dermatol. 2010 Jan;130(1):241-8. doi: 10.1038/jid.2009.182.
There is increasing epidemiological and molecular evidence that cutaneous melanomas arise through multiple causal pathways. The purpose of this study was to explore the relationship between germline and somatic mutations in a population-based series of melanoma patients to reshape and refine the divergent pathway model for melanoma. Melanomas collected from 123 Australian patients were analyzed for melanocortin-1 receptor (MC1R) variants and mutations in the BRAF and NRAS genes. Detailed phenotypic and sun exposure data were systematically collected from all patients. We found that BRAF-mutant melanomas were significantly more likely from younger patients and those with high nevus counts, and were more likely in melanomas with adjacent neval remnants. Conversely, BRAF-mutant melanomas were significantly less likely in people with high levels of lifetime sun exposure. We observed no association between germline MC1R status and somatic BRAF mutations in melanomas from this population. BRAF-mutant melanomas have different origins from other cutaneous melanomas. These data support the divergent pathways hypothesis for melanoma, which may require a reappraisal of targeted cancer prevention activities.
越来越多的流行病学和分子证据表明,皮肤黑色素瘤是通过多种因果途径产生的。本研究的目的是探讨基于人群的黑色素瘤患者中种系和体细胞突变之间的关系,以重塑和完善黑色素瘤的不同途径模型。对 123 名澳大利亚患者的黑色素瘤进行了分析,以检测黑色素皮质素-1 受体 (MC1R) 变体和 BRAF 和 NRAS 基因的突变。从所有患者系统地收集了详细的表型和阳光暴露数据。我们发现,BRAF 突变型黑色素瘤更可能发生在年轻患者和黑色素瘤中存在大量痣细胞残余的患者中,且更可能发生在有相邻痣细胞残余的黑色素瘤中。相反,BRAF 突变型黑色素瘤在一生中接受高水平阳光照射的人群中发生的可能性较小。我们没有观察到人群中黑色素瘤的种系 MC1R 状态与体细胞 BRAF 突变之间存在关联。BRAF 突变型黑色素瘤与其他皮肤黑色素瘤起源不同。这些数据支持黑色素瘤的不同途径假说,这可能需要重新评估靶向癌症预防活动。